2023 ends with big game changers for GU cancers
November 4, 2023Read moreChaired by Prof. Axel Merseburger (DE), Prof. Karim Fizazi (FR) and Prof. Valerie Fonteyne (BE), the game-changing session on...
0
New NMIBC modalities in AS, systemic and intravesical therapies
November 4, 2023Read morePlenary Session 5 “Innovative concepts and new modalities of treatment in urothelial carcinomas” focused on topics such as systemic...
Shorter treatment, better imaging for high-risk PCa?
November 3, 2023Read moreCo-chaired by Assoc. Prof. Juan Gómez Rivas (ES), Prof. Peter Hoskin (GB), Assoc. Prof. Daniela Oprea-Lager (NL) and Prof....
“If you can’t measure it, you can’t improve it”
November 3, 2023Read moreDay two of EMUC23 introduced and implemented the morbidity and mortality (M&M) meeting format during the aptly-titled Plenary Session...
EMUC23: What’s new in GU screening?
November 3, 2023Read moreWhat are the novel developments in genito-urinary (GU) cancer screening? Plenary Session 1 “Genito-urinary cancer screening in 2023” explored...
EMUC23 tackles current challenges of PSMA PET/CT in PCa
November 2, 2023Read morePlenary Session 5 “Nuclear medicine in urology: Lessons learnt and new horizons” of the EAU Section of Urological Imaging (ESUI)...
ESUP: A review of biomarkers and molecular tests in bladder urothelial carcinoma
November 2, 2023Read moreThe Uropathology Symposium of the EAU Section of Uropathology (ESUP) delivered the latest updates on biomarkers and molecular tests...
ESUI meeting examines novel imaging trials
November 2, 2023Read moreToday, Plenary Session 3 of the EAU Section of Urological Imaging (ESUI) meeting examined the latest evidence in three...
ESUI: Getting ready for the new EU approach to PCa screening
November 2, 2023Read moreThis year, the annual EAU Section of Urological Imaging (ESUI) meeting has been integrated into the 15th European Multidisciplinary...
